摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-amino-3-(3''-hydroxy-1''-propynyl)-1-(2',3',5'-tri-O-benzoyl-β-D-ribofuranosyl)-1H-pyrazolo[3,4-d]pyrimidine | 1185880-34-5

中文名称
——
中文别名
——
英文名称
4-amino-3-(3''-hydroxy-1''-propynyl)-1-(2',3',5'-tri-O-benzoyl-β-D-ribofuranosyl)-1H-pyrazolo[3,4-d]pyrimidine
英文别名
——
4-amino-3-(3''-hydroxy-1''-propynyl)-1-(2',3',5'-tri-O-benzoyl-β-D-ribofuranosyl)-1H-pyrazolo[3,4-d]pyrimidine化学式
CAS
1185880-34-5
化学式
C34H27N5O8
mdl
——
分子量
633.617
InChiKey
IWSKNLBRNQIIJF-QWOIFIOOSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.96
  • 重原子数:
    47.0
  • 可旋转键数:
    8.0
  • 环数:
    6.0
  • sp3杂化的碳原子比例:
    0.18
  • 拓扑面积:
    177.98
  • 氢给体数:
    2.0
  • 氢受体数:
    13.0

反应信息

  • 作为反应物:
    描述:
    4-amino-3-(3''-hydroxy-1''-propynyl)-1-(2',3',5'-tri-O-benzoyl-β-D-ribofuranosyl)-1H-pyrazolo[3,4-d]pyrimidine叔丁基二甲基氯硅烷4-二甲氨基吡啶三乙胺 作用下, 以 二氯甲烷 为溶剂, 反应 12.0h, 以79%的产率得到4-amino-3-(3''-(tert-butyldimethylsilyloxy)prop-1''-ynyl)-1-(2',3',5'-tri-O-benzoyl-β-D-ribofuranosyl)-1H-pyrazolo[3,4-d]pyrimidine
    参考文献:
    名称:
    Matching Active Site and Substrate Structures for an RNA Editing Reaction
    摘要:
    The RNA-editing adenosine deaminases (ADARs) catalyze deamination of adenosine to inosine in a double-stranded structure found in various RNA substrates, including mRNAs. Here we present recent efforts to define structure/activity relationships for the ADAR reaction. We describe the synthesis of new phosphoramidites for the incorporation of 7-substituted-8-aza-7-deazaadenosine derivatives into RNA. These reagents were used to introduce the analogues into mimics of the R/G-editing site found in the pre-mRNA for the human glutamate receptor B subunit (GluR B). Analysis of the kinetics of the ADAR2 reaction with analogue-containing RNAs indicated 8-aza-7-deazaadenosine is an excellent substrate for this enzyme with a deamination rate eight times greater than that for adenosine. However, replacing the C7 hydrogen in this analogue with bromine, iodine, or propargyl alcohol failed to increase the deamination rate further but rather decreased the rate. Modeling of nucleotide binding in the enzyme active site suggested amino acid residues that may be involved in nucleotide recognition. We carried out a functional screen of a library of ADAR2 mutants expressed in S. cerevisiae that varied the identity of these residues to identify active deaminases with altered active sites. One of these mutants (ADAR2 R455A) was able to substantially overcome the inhibitory effect of the bulky C7 substituents (-Br, -I, propargyl alcohol). These results advance our understanding of the importance of functional groups found in the edited nucleotide and the role of specific active site residues of ADAR2.
    DOI:
    10.1021/ja9034076
  • 作为产物:
    描述:
    2-丙炔-1-醇 、 (2R,3R,4R,5R)-2-(4-amino-3-iodo-1H-pyrazolo[3,4-d]pyrimidin-1-yl)-5-[(benzoyloxy)methyl]tetrahydrofuran-3,4-diyl dibenzoate 在 copper(l) iodide四(三苯基膦)钯三乙胺 作用下, 以 N,N-二甲基甲酰胺 为溶剂, 以86%的产率得到4-amino-3-(3''-hydroxy-1''-propynyl)-1-(2',3',5'-tri-O-benzoyl-β-D-ribofuranosyl)-1H-pyrazolo[3,4-d]pyrimidine
    参考文献:
    名称:
    Matching Active Site and Substrate Structures for an RNA Editing Reaction
    摘要:
    The RNA-editing adenosine deaminases (ADARs) catalyze deamination of adenosine to inosine in a double-stranded structure found in various RNA substrates, including mRNAs. Here we present recent efforts to define structure/activity relationships for the ADAR reaction. We describe the synthesis of new phosphoramidites for the incorporation of 7-substituted-8-aza-7-deazaadenosine derivatives into RNA. These reagents were used to introduce the analogues into mimics of the R/G-editing site found in the pre-mRNA for the human glutamate receptor B subunit (GluR B). Analysis of the kinetics of the ADAR2 reaction with analogue-containing RNAs indicated 8-aza-7-deazaadenosine is an excellent substrate for this enzyme with a deamination rate eight times greater than that for adenosine. However, replacing the C7 hydrogen in this analogue with bromine, iodine, or propargyl alcohol failed to increase the deamination rate further but rather decreased the rate. Modeling of nucleotide binding in the enzyme active site suggested amino acid residues that may be involved in nucleotide recognition. We carried out a functional screen of a library of ADAR2 mutants expressed in S. cerevisiae that varied the identity of these residues to identify active deaminases with altered active sites. One of these mutants (ADAR2 R455A) was able to substantially overcome the inhibitory effect of the bulky C7 substituents (-Br, -I, propargyl alcohol). These results advance our understanding of the importance of functional groups found in the edited nucleotide and the role of specific active site residues of ADAR2.
    DOI:
    10.1021/ja9034076
点击查看最新优质反应信息

同类化合物

硫代嘌呤醇核糖核苷 硝基苄基硫代间型霉素 别嘌呤醇核糖苷 [3,4-二乙酰氧基-5-(5-甲硫基-2,4,8,9-四氮杂双环[4.3.0]壬-2,4,7,10-四烯-9-基)四氢呋喃-2-基]甲基乙酸酯 6-氮杂卡德勾霉素 6-氨基别嘌呤醇核糖甙 4-氨基-3-苄基-1H-吡唑并[3,4-d]嘧啶-1-β-D-呋喃核糖 1 beta-呋喃核糖基-4-(甲硫基)吡唑并(3,4-d)嘧啶 1-β-D-ribofuranosylpyrazolo<3,4-d>pyrimidine-4-sulfenamide 4-amino-3-(3''-hydroxy-1''-propynyl)-1-(2',3',5'-tri-O-benzoyl-β-D-ribofuranosyl)-1H-pyrazolo[3,4-d]pyrimidine 1-(2,3,5-tri-O-acetyl-β-D-ribofuranosyl)pyrazolo<3,4-d>pyrimidine-4-carbonitrile 1-(2',3',5'-Tri-O-acetyl-β-D-ribofuranosyl)-3-cyano-4-methylmercaptopyrazolo<3,4-d>pyrimidine Acetic acid (2R,3R,4R,5R)-4-acetoxy-5-acetoxymethyl-2-(4-methanesulfonyl-pyrazolo[3,4-d]pyrimidin-1-yl)-tetrahydro-furan-3-yl ester 8-aza-7-deaza-7-[(5,7-di-tert-butylbenzoxazol-2-yl)ethynyl]adenosine (2R,3R,4S,5R)-2-{4-[(E)-3-(2,4-Dichloro-phenyl)-allylsulfanyl]-pyrazolo[3,4-d]pyrimidin-1-yl}-5-hydroxymethyl-tetrahydro-furan-3,4-diol 3-(methylthio)-1-β-D-ribofuranosylpyrazolo<3,4-d>pyrimidin-4(5H)-one 3-chloro-1-(β-D-ribofuranosyl)-1H-pyrazolo[3,4-d]pyrimidine-4,6-diamine 1-(2,3,4,6-Tetra-O-benzyl-β-D-glucopyranosyl)-1,5-dihydro-4H-pyrazolo-<3,4-d>pyrimidin-4-on (2R,3R,4S,5R)-2-{4-[(E)-3-(3,4-Dichloro-phenyl)-allylsulfanyl]-pyrazolo[3,4-d]pyrimidin-1-yl}-5-hydroxymethyl-tetrahydro-furan-3,4-diol 1-(2,3,4,6-Tetra-O-benzyl-β-D-glucopyranosyl)-1H-pyrazolo<3,4-d>pyrimidin-4-amin (2S,3R,4S,5R)-2-(4-amino-3-phenylpyrazolo[3,4-d]pyrimidin-1-yl)-5-hydroxymethyltetrahydrofuran-3,4-diol 1-(β-D-arabinofuranosyl)-1H-pyrazolo<3.4-d>pyrimidin-4-one 1-(2,3,5-tri-O-benzyl-β-D-arabinofuranosyl)-1H-pyrazolo<3.4-d>pyrimidin-4-one (2R,3R,4S,5R)-2-(4-Dihexylamino-pyrazolo[3,4-d]pyrimidin-1-yl)-5-hydroxymethyl-tetrahydro-furan-3,4-diol 4-(butylamino)-1-β-D-ribofuranosyl-1H-pyrazolo<3,4-d>pyrimidine 6-O-ethylinosine 1-(β-D-Ribofuranosyl)-3-carbamoyl-4,6-dimethylmercaptopyrazolo<3,4-d>pyrimidine 1-N-ethylinosine 6-amino-3-methyl-1-β-D-ribofuranosylpyrazolo<3,4-d>pyrimidin-4(5H)-one 1-(2',3',5'-tri-O-acetyl-β-D-ribofuranosyl)-3-thiocarbamoyl-4,6-dimethylmercaptopyrazolo<3,4-d>pyrimidine 1-(β-D-Ribofuranosyl)-4-amino-6-methylmercapto-3-carbamoylpyrazolo<3,4-d>pyrimidine 1-(β-D-Ribofuranosyl)-3-carbamoyl-4-amino-6-methylsulfonylpyrazolo<3,4-d>pyrimidine 6-Methylthio-4(5H)-oxo-1-β-D-ribofuranosylpyrazolo<3,4-d>pyrimidine 4,6-Dimethylthio-1-α-(2,3,5-tri-O-acetyl-D-xylofuranosyl)pyrazolo<3,4-d>pyrimidine 1-(β-D-Ribofuranosyl)-3-carbamoyl-4,6-diaminopyrazolo<3,4-d>pyrimidine 6-amino-4-methoxy-1-α-D-arabinofuranosylpyrazolo<3,4-d>pyrimidine 6-Methylthio-4(5H)-oxo-1-α-D-xylofuranosylpyrazolo<3,4-d>pyrimidine 6-Amino-4(5H)-oxo-1-α-D-xylofuranosylpyrazolo<3,4-d>pyrimidine N-<(6-amino-1-β-D-ribofuranosyl-4,5-dihydro-4-oxopyrazolo<3,4-d>pyrimidin-3-yl)carbonyl>glycine amide 4,6-Dimethylthio-1-α-D-xylofuranosylpyrazolo<3,4-d>pyrimidine 4,6-dimethylthio-1-α-D-arabinofuranosylpyrazolo<3,4-d>pyrimidine 4-methoxy-6-methylsulphonyl-1-α-(2,3,5-tri-O-acetyl-D-arabinofuranosyl)pyrazolo<3,4-d>pyrimidine 4-amino-6-methylthio-1-α-D-arabinofuranosylpyrazolo<3,4-d>pyrimidine 4-amino-6-methylsulphonyl-1-α-D-arabinofuranosylpyrazolo<3,4-d>pyrimidine 4-acetamido-6-methylsulphonyl-1-α-(2,3,5-tri-O-acetyl-D-arabinofuranosyl)pyrazolo<3,4-d>pyrimidine 4-amino-6-methoxy-1-α-D-arabinofuranosylpyrazolo<3,4-d>pyrimidine 4.6-Diamino-1-β-ribofuranosyl-1H-pyrazolo<3.4-d>pyrimidin 1-(N-Methyl-β-D-ribofuranuronamidosyl)-1H-pyrazolo<3,4-d>pyrimidin-4-amin 4-methoxy-6-methylthio-1-α-(2,3,5-tri-O-acetyl-D-arabinofuranosyl)pyrazolo<3,4-d>pyrimidine 1-β-D-ribofuranosyl-4(5H)-thioxopyrazolo<3,4-d>pyrimidine-3-carbonitrile